Ardelyx (ARDX) Stock Forecast & Price Target

Compare

1,744 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARDX Analyst Ratings

Strong Buy

9 Buy

2 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Ardelyx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARDX Stock 12 Month Forecast

Average Price Target

$10.75

▲(73.67% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Ardelyx in the last 3 months. The average price target is $10.75 with a high forecast of $15.00 and a low forecast of $5.50. The average price target represents a 73.67% change from the last price of $6.19.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","9":"$9","16":"$16","5.5":"$5.5","12.5":"$12.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.5,9,12.5,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.33,5.150769230769231,5.9715384615384615,6.792307692307693,7.613076923076923,8.433846153846154,9.254615384615384,10.075384615384616,10.896153846153847,11.716923076923077,12.537692307692309,13.358461538461539,14.17923076923077,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.33,4.823846153846154,5.317692307692308,5.811538461538461,6.305384615384615,6.799230769230769,7.293076923076923,7.786923076923077,8.28076923076923,8.774615384615384,9.268461538461539,9.762307692307692,10.256153846153847,{"y":10.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.33,4.42,4.51,4.6,4.69,4.78,4.87,4.96,5.05,5.14,5.23,5.32,5.41,{"y":5.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.57,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.5,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.85,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.09,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.54,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.79,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.85,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$15.00

Average Price Target$10.75

Lowest Price Target$5.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Dex Genotek

TR | OpenAI - 4o

$5.5

Hold

-11.15%

Downside

Reiterated

08/20/25

AI Generated ArticleAI Generated Article

Allison Bratzel

Piper Sandler

$8→$9

Hold

45.40%

Upside

Reiterated

08/06/25

Ardelyx price target raised to $9 from $8 at Piper SandlerArdelyx price target raised to $9 from $8 at Piper Sandler

Ryan Deschner

Raymond James

$11→$12

Buy

93.86%

Upside

Reiterated

08/05/25

Ardelyx (ARDX) Gets a Buy from Raymond James

Matthew Caufield

H.C. Wainwright

$10

Buy

61.55%

Upside

Reiterated

08/05/25

Ardelyx's Strong Commercial Execution and Growth Prospects Drive Buy Rating

Joseph Thome

TD Cowen

Buy

45.40%

Upside

Reiterated

08/05/25

Ardelyx's Strong Performance and Sales Outlook Justify Buy RatingWe have updated our 2025 sales estimate to $255MME from $241MME.

Roanna Ruiz

Leerink Partners

$10→$11

Buy

77.71%

Upside

Reiterated

08/05/25

Ardelyx's Strong Financial Performance and Strategic Positioning Drive Buy Rating and Increased Price Target

Louise Chen

Scotiabank

$15

Buy

142.33%

Upside

Reiterated

08/05/25

Scotiabank Sticks to Its Buy Rating for Ardelyx (ARDX)

Unknown Analyst

Wedbush

Not Ranked

Wedbush

$13→$14

Buy

126.17%

Upside

Reiterated

08/05/25

Wedbush Sticks to Their Buy Rating for Ardelyx (ARDX)

Julian Harrison

BTIG

$14

Buy

126.17%

Upside

Reiterated

07/28/25

Ardelyx's Promising Growth Potential and Market Positioning: A Buy RecommendationArdelyx, Inc. (ARDX, Buy, $14 PT) with Revisions table showing Previous: Buy and Current: Buy; our PT remains unchanged ahead of 2Q25 earnings.

Prakhar Agrawal

Cantor Fitzgerald

―

Buy

―

Reiterated

07/07/25

Cantor Fitzgerald reiterates Overweight Rating on Ardelyx, Inc (ARDX)Cantor Fitzgerald analyst Louis Chen reiterated an Overweight rating on Ardelyx, Inc (NASDAQ: ARDX).

Dennis Ding

Jefferies

Buy

29.24%

Upside

Reiterated

07/02/25

Ardelyx's Legal Battle and Potential Growth: Analyst Recommends Buy Amidst Xphozah's CMS Appeal

Yigal Nochomovitz

Citi

$11→$10

Buy

61.55%

Upside

Reiterated

05/02/25

Ardelyx price target lowered to $10 from $11 at CitiArdelyx price target lowered to $10 from $11 at Citi

Aydin Huseynov

Ladenburg Thalmann & Co.

$13.5→$11

Buy

77.71%

Upside

Reiterated

03/07/25

Ardelyx price target lowered to $11 from $13.50 at LadenburgArdelyx price target lowered to $11 from $13.50 at Ladenburg

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Dex Genotek

TR | OpenAI - 4o

$5.5

Hold

-11.15%

Downside

Reiterated

08/20/25

AI Generated ArticleAI Generated Article

Allison Bratzel

Piper Sandler

$8→$9

Hold

45.40%

Upside

Reiterated

08/06/25

Ardelyx price target raised to $9 from $8 at Piper SandlerArdelyx price target raised to $9 from $8 at Piper Sandler

Ryan Deschner

Raymond James

$11→$12

Buy

93.86%

Upside

Reiterated

08/05/25

Ardelyx (ARDX) Gets a Buy from Raymond James

Matthew Caufield

H.C. Wainwright

$10

Buy

61.55%

Upside

Reiterated

08/05/25

Ardelyx's Strong Commercial Execution and Growth Prospects Drive Buy Rating

Joseph Thome

TD Cowen

Buy

45.40%

Upside

Reiterated

08/05/25

Ardelyx's Strong Performance and Sales Outlook Justify Buy RatingWe have updated our 2025 sales estimate to $255MME from $241MME.

Roanna Ruiz

Leerink Partners

$10→$11

Buy

77.71%

Upside

Reiterated

08/05/25

Ardelyx's Strong Financial Performance and Strategic Positioning Drive Buy Rating and Increased Price Target

Louise Chen

Scotiabank

$15

Buy

142.33%

Upside

Reiterated

08/05/25

Scotiabank Sticks to Its Buy Rating for Ardelyx (ARDX)

Unknown Analyst

Wedbush

Not Ranked

Wedbush

$13→$14

Buy

126.17%

Upside

Reiterated

08/05/25

Wedbush Sticks to Their Buy Rating for Ardelyx (ARDX)

Julian Harrison

BTIG

$14

Buy

126.17%

Upside

Reiterated

07/28/25

Prakhar Agrawal

Cantor Fitzgerald

―

Buy

―

Reiterated

07/07/25

Cantor Fitzgerald reiterates Overweight Rating on Ardelyx, Inc (ARDX)Cantor Fitzgerald analyst Louis Chen reiterated an Overweight rating on Ardelyx, Inc (NASDAQ: ARDX).

Dennis Ding

Jefferies

Buy

29.24%

Upside

Reiterated

07/02/25

Ardelyx's Legal Battle and Potential Growth: Analyst Recommends Buy Amidst Xphozah's CMS Appeal

Yigal Nochomovitz

Citi

$11→$10

Buy

61.55%

Upside

Reiterated

05/02/25

Ardelyx price target lowered to $10 from $11 at CitiArdelyx price target lowered to $10 from $11 at Citi

Aydin Huseynov

Ladenburg Thalmann & Co.

$13.5→$11

Buy

77.71%

Upside

Reiterated

03/07/25

Ardelyx price target lowered to $11 from $13.50 at LadenburgArdelyx price target lowered to $11 from $13.50 at Ladenburg

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ardelyx

1 Month

xxx

Success Rate

10/15 ratings generated profit

Average Return

+5.01%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +5.01% per trade.

3 Months

xxx

Success Rate

4/6 ratings generated profit

Average Return

-0.18%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -0.18% per trade.

1 Year

Louise ChenScotiabank

Success Rate

5/6 ratings generated profit

Average Return

+20.15%

reiterated a buy rating 24 days ago

Copying Louise Chen's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +20.15% per trade.

2 Years

xxx

Success Rate

5/6 ratings generated profit

Average Return

+19.00%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +19.00% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARDX Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARDX has received 12 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ARDX average Analyst price target in the past 3 months is 10.75.

Each month's total comprises the sum of three months' worth of ratings.

ARDX Financial Forecast

ARDX Earnings Forecast

Next quarter’s earnings estimate for ARDX is -$0.06 with a range of -$0.09 to -$0.01. The previous quarter’s EPS was -$0.08. ARDX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.22% of the time in the same period. In the last calendar year ARDX has Outperformed its overall industry.

ARDX Sales Forecast

Next quarter’s sales forecast for ARDX is $100.73M with a range of $94.60M to $109.86M. The previous quarter’s sales results were $97.66M. ARDX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.92% of the time in the same period. In the last calendar year ARDX has Outperformed its overall industry.

ARDX Stock Forecast FAQ

What is ARDX’s average 12-month price target, according to analysts?

Based on analyst ratings, Ardelyx’s 12-month average price target is 10.75.

What is ARDX’s upside potential, based on the analysts’ average price target?

Ardelyx has 73.67% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARDX a Buy, Sell or Hold?

Ardelyx has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.

What is Ardelyx’s price target?

The average price target for Ardelyx is 10.75. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $5.50. The average price target represents 73.67% Increase from the current price of $6.19.

What do analysts say about Ardelyx?

Ardelyx’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of ARDX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Ardelyx (ARDX) Stock Forecast & Price Target

ARDX Analyst Ratings

ARDX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Ardelyx

ARDX Analyst Recommendation Trends

ARDX Financial Forecast

ARDX Earnings Forecast

ARDX Sales Forecast

ARDX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts